What’s Happening at GRS News letter #1; March 1 st, 2011 Visit: GRS-IGF 2010 Meeting in NYC – Oct. 3-7, 2010 – 351 Attendees.

Slides:



Advertisements
Similar presentations
6th European Patients’ Rights Day The EMA Geriatric Medicines Strategy and the empowered aging patient Francesca Cerreta EMA (European Medicines Agency)
Advertisements

International Society for Heart and Lung Transplantation 2010 Annual Report International Society for Heart and Lung Transplantation: A Forum that Includes.
Pulmonary Hypertension Council Report Robert P. Frantz, MD April 21, 2012 Prague.
1 Advisory Council April 1, 2011 Child Care Development Fund – State Plan for Federal Fiscal Years 2012 and 2013.
First European Workshop on Ataxia-Telangiectasia Clinical Science for A-T: Status Quo and Future Directions Dear Colleagues, we have the pleasure to invite.
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDAs website for reference purposes only. It.
Overview of diet related diseases
Introduction to the Endocrine System
American Chemical Society Local Section Track Sunday Morning January 26, 2014 Mitchell Bruce, 2013 Chair, Committee on Local Section Activities (LSAC)
Code of Student Conduct (CSC) Tutorial Lesson 4 Adopting and Implementing Your CSC – The Rewards of Long-Term Investment This tutorial has been prepared.
Nanotechnology and cancer Maria Guirguis Dr. Sun Biomedical Engineering Seminar 1.
Project Management Education at Columbia Basin College For-Credit & Continuing Education AACE International - 4/17/20121.
Search Strategy and Information Retrieval By Rekha Gupta, NIC
PUBLIC RELATIONS - UPDATE 7080 Public Image Citation criteria Dec 4, 2012.
St. John Ambulance Council for Ontario Mission Statement.
Nadia Konzali Project Coordinator, COSCAP-GS
American Chemical Society Welcome to the “Preparing for Your Term as Chair” webinar Please perform a systems check if you have not done so. This will ensure.
Presentation to Lancaster City Council OSC 11 June 2014 Update on the Clinical Strategy for Health Services in Morecambe Bay: Better Care Together.
Childhood obesity in Merton including an update on the NCMP programme
Center for Clinical Research - Clinical Trials Center (CTC) Clinical Research and Clinical Trials in Switzerland Jürg Lustenberger, PhD Dipl. Pharm. Med.
The Importance of Individual Patient Response in Clinical Trials Group 8: Zhiyuan Xu, Yiwen Zhang, Chelsea Nichols, Lu Wang, Nadir Demirel, Travis Myers.
WIOA Timeline and Action Plan for States
Andrew Emili Ontario Research Chair in Biomarkers of Clinical Management Donnelly Center, UofT Biomarker Discovery 2012 Symposium of Ontario Research Chairs.
By: Garabed Tashian.  Biomedical engineering is the application of engineering principles and techniques to the medical field.  Closes the gap between.
Biology of Lipid Metabolism Laboratory. People Lab head Matthew Watt Research Assistant Maria Matzaris.
Insulin Signaling – Insulin Resistance Elmus G. Beale, Professor Texas Tech University Health Sciences Center Paul L. Foster School of Medicine PhD, Baylor.
27803::Systems Biology1CBS, Department of Systems Biology Schedule for the Afternoon 13:00 – 13:30ChIP-chip lecture 13:30 – 14:30Exercise 14:30 – 14:45Break.
Schedule for the Afternoon 13:00 – 13:30ChIP-chip lecture 13:30 – 14:30Exercise 14:30 – 14:45Break 14:45 – 15:15Regulatory pathways lecture 15:15 – 15:45Exercise.
Phosphatase and Tensin Homolog Deleted on Chromosome 10
Human Growth Hormone (HGH) By Alex Fahnestock. Where is it produced?  The Human Growth Hormone is produced by the pituitary glands  Usually it is produced.
HISTORY OF MEDICAL BIOTECHNOLOGY CHANGES IN THE LAST 15 YEARS.
15.2 Regulation of Transcription & Translation
Insulin-Like Growth Factor 1 Matthew Klinka
Phylogeny in Drug Discovery?
Chapter 45 Hormones and the Endocrine System.
Insulin-like signaling pathway: flies and mammals
CS 790 – Bioinformatics Introduction and overview.
Molecular and Cellular Basis of Disease (MCBD). Cell Injury.
Growth Hormone Victoria Brown.
Regulating the Cell Cycle and Cancer Ms. Cohen. How carefully do cells divide? Quite controlled Some cells divide at different rates –Cells that divide.
Consortium for Interdisciplinary Studies on Science for Aging.
○ Area Yonsei Biomedical Science and Technology Initiative (YBSTI)
Understanding Cancer and Related Topics
瘦體素 Obesity and Leptin WT ob (db) 2010 Albert Lasker award
Defining Insulin-Like Growth Factor-I Deficiency
MAKE A LOGBOOK ENTRY TITLED “GROWTH HORMONE NETWORK”
Diabetes. Diabetes: Disease that prevents body from converting food to energy Insulin: Hormone that regulates blood glucose levels.
The Leukemia & Lymphoma Society Indiana Chapter 9075 N. Meridian St., Suite 150 Indianapolis, IN Elissa Evernham, Campaign Director |
Growth Hormone – A Pituitary Hormone Lecture NO : 2nd MBBS
GnRH-I AND II INDUCED EFFECTS IN HUMAN OVARIAN CELLS
Cancer Prevention and Screening
Cell Communication: A Review
Health & Biomedicine.
NASPCC 2017/2018 WorkPlan Status Report
A powerful new agonist: flooding the system with growth hormone
Christine A. Sorkness, PharmD 
ENDOCRINE SYSTEM Insulin Growth Hormone Gastrin
Figure 1 Treatment-induced resistance and evolution to lineage crisis
Schedule for the Afternoon
Selective estrogen receptor modulation
Psychiatric Disorders: Diagnosis to Therapy
The International Consortium for Personalised Medicine
GROWTH HORMONE Victoria Brown. Structure of hormone  191 amino acids long  Protein structure  4 helices that help it bind its receptor  2 strong sulfide.
Michael D. Brooks, Monika L. Burness, Max S. Wicha  Cell Stem Cell 
Is Growth Hormone Resistance/IGF-1 Reduction Good for You?
Psychiatric Disorders: Diagnosis to Therapy
Ophélie Meynet, Jean-Ehrland Ricci  Trends in Molecular Medicine 
Do Cancer Cells Care If Their Host Is Hungry?
The new kid on the block(ade) of the IGF-1 receptor
Presentation transcript:

What’s Happening at GRS News letter #1; March 1 st, 2011 Visit: GRS-IGF 2010 Meeting in NYC – Oct. 3-7, 2010 – 351 Attendees – Student travel awards; 79 travel grants totaling $82,500 WOW!! – Thanks to Derek LeRoith and the LOC and POC for putting together a great meeting! Selected Plenary Talks at the Meeting D. Sinclair: Longevity genes, parlor trick or path to drugs that revolutionize medicine D. Berryman: GH and fat distribution: To be and where to be M. Korbonitis: The curious case of Ghrelin R. Baxter: Who needs IGFs? IGFBP3 activates growth –stimulatory pathways B. Forbes; Molecular mechanisms underlying IGF action A. Lee: Targeting the IGF pathways in breast cancer M. Kjaer: Role of GH/IGF-1 in adaptation of matrix in skeletal muscle and tendon to exercise V. Longo: Conserved IGF-1 regulated genes and the prevention and treatment of age-related diseases D. Waxman: Genomic approaches to unraveling the complexity of GH-regulated liver sex differences M. Bidlingmaier: Diagnostic guidelines and GH assay variability M. Holzenberger: IGF-1 receptor in adults: What the cell-specific knockouts tell us S. Camper: Strategies for identifying genes involved in cell lineage specification and expansion: from stem cell to hormone producing cells. Upcoming Events – Prader-Willi Workshop Montreal, (Oct 3-6, 2011) – GRS-IGF Meeting Munich (Oct 16-20, 2012) See advertisement below!! – GRS-IGF Meeting Singapore (Oct 14-19, 2014) – GRS-IGF Meeting (2016, TBD) – Other Upcoming Workshops (dates TBD) IGF1 deficiency Safety of rhGH treatment

What’s Happening at GRS Page 2 Visit: Supporting Member News GRS Council Supporting Member Meeting, NYC, Oct. 5, 2011 A direct dialogue between GRS and Supporting Members was established during the recent NYC meeting which was quite valuable for its constructive input. GRS intends to continue and institutionalize these types of meetings. Supporting Member Sponsored Satellite Sessions at our Meetings Now Approved The timing of satellite meetings must not conflict with GRS meeting times – They could occur before or after the GRS-IGF meeting or could be held as a breakfast meeting Host of the Satellite meeting will organize and support the entire event Speakers for the Satellite meeting must be submitted to GRS-IGF Program Organizing Committee for approval (so as not to conflict with speakers in the GHR-IGF Meeting) – GRS thanks Supporting Members for your continued and enthusiastic support! Check Out Our ‘Most Recent’ Consensus Statement! Recent Publications Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans. J Guevara-Aguirre, P Balasubramanian, M Guevara-Aguirre, M Wei, F Madia, C Cheng, D Hwang, A Martin-Montalvo, J Saavedra, S Ingles, R de Cabo, P Cohen, V Longo. Science Tranlational Medicine, Vol 3, Issue 70, p 1-9, Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia. F Ricka, A Schallya, N Blocke, M Nadjic, K Szepeshazia, M Zarandia,, I Vidaurrea,b, R Pereza, G Halmosa, and L Szalontaya. Proc Natl Acad Sci U S A. Feb [Epub ahead of print] The growth hormone receptor: mechanism of activation and clinical implications. A Brooks & M Waters. Nature Reviews Endocrinology, 6, p ), 2010 Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin like Growth Factor Assays. D Clemmons. Clin Chem. Feb [E pub ahead of print]